VRK1: A protein that reduces the survival of patients with neuroblastoma
Researchers from the Departments of Cell Biology and Medical Physiology at the University of Seville have identified that a high
Read moreResearchers from the Departments of Cell Biology and Medical Physiology at the University of Seville have identified that a high
Read moreResearchers from Kanazawa University retrospectively analyzed children with refractory or relapsed high-risk neuroblastoma who were treated with high-dose 131I-metaiodobenzylguanidine at
Read more